Mayne Pharma reported AUD382.57M in Operating Expenses for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Ansell ANN:AU USD 820M 75.5M
Cochlear COH:AU AUD 662M 75.7M
CSL CSL:AU USD 3.81B 18.5M
Ecofibre Ltd EOF:AU AUD 26.16M 1.73M
Healius Ltd HLS:AU AUD 892.5M 83.8M
Integral Diagnostics Ltd IDX:AU AUD 166.46M 5.15M
Medical Developments International Ltd MVP:AU AUD 19.07M 7.3M
Nanosonics Ltd NAN:AU AUD 61.24M 3.95M
Next Science Ltd NXS:AU USD 11.99M 1.75M
Polynovo Ltd PNV:AU AUD 26.01M 9.75M
Probiotec Ltd PBP:AU AUD 85.41M 6.53M
Ramsay Health Care RHC:AU AUD 6.32B 324.8M
ResMed RMD:AU USD 753.55M 94.21M
Sigma Healthcare Ltd SIG:AU AUD 1.89B 113.08M
Sonic Healthcare SHL:AU AUD 3.64B 87.61M
Telix Pharmaceuticals Ltd TLX:AU AUD 91.43M 41.44M